LOW-VOLUME · SEX-BALANCED
moexipril Side Effects
moexipril (also sold as Univasc) is a LOW-VOLUME FAERS extract #522 of 524 by FAERS report count. Still opens on SEX-BALANCED: 68% of sex-coded reports are female (43 F / 20 M).
Data updated 2026-05-15
- 67
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
moexipril reporting skew - 68% of sex-coded reports are female (43 F / 20 M). Volume band LOW-VOLUME #522 of 524 by FAERS report count; caseload TRACE-CASE.
Thinner FAERS extract for moexipril (Univasc) (67 reports #522 of 524 by FAERS report count). 68% of sex-coded reports are female (43 F / 20 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ASTHENIA leads 8 of 67 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (16 reports)
Reporting taper since 2004 peak
Reactions in Death Reports
Death-mentioned subset is HEAVY here (6 reports, 9.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 3 |
| DYSPNOEA | 2 |
| PNEUMONIA | 2 |
| ANHEDONIA | 1 |
| ANXIETY | 1 |
| ASTHENIA | 1 |
| CANDIDIASIS | 1 |
| CEREBROVASCULAR DISORDER | 1 |
| COUGH | 1 |
| DECREASED APPETITE | 1 |
| DISSEMINATED INTRAVASCULAR COAGULATION | 1 |
| DRUG TOXICITY | 1 |
| DYSPHAGIA | 1 |
| ECCHYMOSIS | 1 |
| ELECTROCARDIOGRAM QRS COMPLEX SHORTENED | 1 |
| EMOTIONAL DISTRESS | 1 |
| FATIGUE | 1 |
| FEAR | 1 |
| HEPATIC FAILURE | 1 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (21, 31.3% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 5 |
| ASTHENIA | 4 |
| CEREBROVASCULAR ACCIDENT | 4 |
| DEHYDRATION | 4 |
| HEADACHE | 3 |
| HYPERTENSION | 3 |
| RENAL FAILURE ACUTE | 3 |
| ARTHROPATHY | 2 |
| BLOOD ALBUMIN DECREASED | 2 |
| BLOOD CREATINE PHOSPHOKINASE DECREASED | 2 |
| BLOOD CREATININE INCREASED | 2 |
| BLOOD PRESSURE DECREASED | 2 |
| BLOOD PRESSURE INCREASED | 2 |
| BLOOD UREA INCREASED | 2 |
| CHEST PAIN | 2 |
| CORONARY ARTERY DISEASE | 2 |
| CREATININE RENAL CLEARANCE DECREASED | 2 |
| DIALYSIS | 2 |
| DIZZINESS | 2 |
| HAEMOGLOBIN DECREASED | 2 |
How to read moexipril FAERS figures (TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 67 voluntary reports linked to moexipril (Univasc), 2004-2025. Death is listed on 6 (9.0%). Hospitalization appears on 21 (31.3%). Top co-reported indication: Hypertension.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with moexipril
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 73 FAERS cases (Δ 6 heavier vs moexipril); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 81 FAERS cases (Δ 14 heavier vs moexipril); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 51 FAERS cases (Δ 16 lighter vs moexipril); DEATH-HEAVY · HOSP-HEAVY · SEX-THIN vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 96 FAERS cases (Δ 29 heavier vs moexipril); DEATH-RARE · HOSP-MID · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 53.2 pp vs moexipril's DEATH-HEAVY): CASELOAD · HOSP-MID.
moexipril stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload TRACE-CASE and the label guide.